Home
-

CDMO Moves: Lonza Increasing Position in US
Lonza is increasing its position in the US with a pending acquisition of five CDMO sites from the life-sciences business of Merck KGaA. What sites and capabilities is the company gaining in the deal?
-

Orphan Drugs: The Top Products & Companies
Orphan drug sales are projected to reach a peak of 30% of the global prescription drug market by 2027 and sales of $400 billion by 2032. What products and companies are leading growth?
-

Anthropic & Pharma: What Comes Next
In what is projected to be one of the largest IPOs in history, the AI giant, Anthropic, has taken the first step in holding an IPO, with AI in bio/pharmaceutical development a key component in its growth strategy.
SPONSORED CONTENT
-

SPONSORED CONTENT
Building Stronger Sponsor and CDMO Partnerships through Clear Communication
-

SPONSORED CONTENT
Next-generation pMDIs: Embedding sustainability across design and development
-

SPONSORED CONTENT
Trends Driving the Biopharmaceutical Industry Forward: How CDMOs Maintain Stability in a Complex Global Market
DCAT MEMBER COMPANY COMMUNITY
-
New DCAT Member Company Alert
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all DCAT Member Companies, visit the Member Directory at the DCAT website. From the November 6, 2026, issue of DCAT Value Chain Insights: From the October…
-
DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the world’s largest international pre-college student science and engineering competition that took place in Phoenix, Arizona from May 9–15, 2026. Owned and produced by the Society for Science, Regeneron…
-
ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis
The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving? In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a roundtable of industry experts share their perspectives on the latest in peptide synthesis. Solid-phase peptide synthesis (SPPS) is the dominant method in peptide synthesis, but other approaches, such…
-
New DCAT Member Company Alert
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all DCAT Member Companies, visit the Member Directory at the DCAT website. From the May 8, 2026, issue of DCAT Value Chain Insights: From the May…




